Quarterly Reports :: Anixa Biosciences, Inc. (ANIX)

Date	Form	Description	Docs	XBRL	Pages
06/09/20	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2			60
03/09/20	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			35
09/06/19	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.1 EX-10.2 EX-31.1 EX-31.2 EX-32.1 EX-32.2			84
06/12/19	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31 EX-31 EX-32 EX-32			39
03/13/19	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			35
09/07/18	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			33
06/11/18	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-3.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2			34
03/09/18	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.2 EX-32.2			31
09/08/17	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			35
05/26/17	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			32

Sep 19, 2023

Anixa Biosciences Establishes Cancer Business Advisory Board

Quarterly Reports